{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:13:43Z","timestamp":1793060023586,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012538","name":"Swedish Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jhep.2019.06.005","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T23:00:14Z","timestamp":1560466814000},"page":"673-684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E"],"prefix":"10.1016","volume":"71","author":[{"given":"Chai Fen","family":"Soon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Behrendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3564-1014","authenticated-orcid":false,"given":"Daniel","family":"Todt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Peter","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"S\u00e4llberg Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Cornberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2019.06.005_b0005","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1053\/j.gastro.2012.02.014","article-title":"Pathogenesis and treatment of hepatitis E Virus Infection","volume":"142","author":"Wedemeyer","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.06.005_b0010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jhep.2016.02.045","article-title":"Update on hepatitis E virology: implications for clinical practice","volume":"65","author":"Debing","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.06.005_b0015","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(14)61034-5","article-title":"Hepatitis E virus in blood components: a prevalence and transmission study in southeast England","volume":"384","author":"Hewitt","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2019.06.005_b0020","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jhep.2014.08.047","article-title":"The impact of hepatitis E in the liver transplant setting","volume":"61","author":"Behrendt","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.06.005_b0025","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jhep.2018.03.005","article-title":"EASL clinical practice guidelines on hepatitis E virus infection","volume":"68","author":"EASL","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.06.005_b0030","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","article-title":"Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants","volume":"140","author":"Kamar","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.06.005_b0035","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMoa1215246","article-title":"Ribavirin for chronic hepatitis E virus infection in transplant recipients","volume":"370","author":"Kamar","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2019.06.005_b0040","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1007\/s10620-013-2628-7","article-title":"Chronic hepatitis E with neurologic manifestations and rapid progression of liver fibrosis in a liver transplant recipient","volume":"58","author":"Maddukuri","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2019.06.005_b0045","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1136\/gutjnl-2015-311000","article-title":"In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome","volume":"65","author":"Todt","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.06.005_b0050","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2016.05.002","article-title":"Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity","volume":"65","author":"Debing","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.06.005_b0055","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.24738","article-title":"Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection","volume":"55","author":"Suneetha","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.06.005_b0060","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2019.06.005_b0065","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jhep.2014.10.001","article-title":"Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient","volume":"62","author":"Qasim","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.06.005_b0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jviromet.2005.07.004","article-title":"A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus","volume":"131","author":"Jothikumar","year":"2006","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jhep.2019.06.005_b0075","doi-asserted-by":"crossref","first-page":"W525","DOI":"10.1093\/nar\/gks438","article-title":"Immune epitope database analysis resource","volume":"40","author":"Kim","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhep.2019.06.005_b0080","doi-asserted-by":"crossref","first-page":"8304","DOI":"10.1128\/JVI.00539-15","article-title":"Frequency, private specificity, and cross-reactivity of preexisting hepatitis C virus (HCV)-specific CD8+ T cells in HCV-seronegative individuals: implications for vaccine responses","volume":"89","author":"Zhang","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2019.06.005_b0085","doi-asserted-by":"crossref","first-page":"8878","DOI":"10.1158\/0008-5472.CAN-06-1450","article-title":"Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR\/CD3 stability","volume":"66","author":"Cohen","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2019.06.005_b0090","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00010-17","article-title":"Hepatitis C virus-specific T cell receptor mRNA-engineered human T cells: impact of antigen specificity on functional properties","volume":"91","author":"Balasiddaiah","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2019.06.005_b0095","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.4049\/jimmunol.1201613","article-title":"TCR-Redirected human T cells inhibit hepatitis C virus replication: hepatotoxic potential is linked to antigen specificity and functional avidity","volume":"189","author":"Pasetto","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2019.06.005_b0100","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/hep.28819","article-title":"Characterization of the specificity, functionality and durability of host T cell responses against the full length hepatitis E virus","volume":"64","author":"Brown","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.06.005_b0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/j.gastro.2017.09.020","article-title":"Hepatitis E Virus lifecycle and identification of 3 forms of the ORF2 capsid protein","volume":"154","author":"Montpellier","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.06.005_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/mtna.2013.43","article-title":"A practical approach to immunotherapy of HCC using T cells redirected against hepatitis B Virus","volume":"2","author":"Koh","year":"2013","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jhep.2019.06.005_b0115","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.jcyt.2017.07.011","article-title":"T-cell therapy for chronic viral hepatitis","volume":"19","author":"Bertoletti","year":"2017","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jhep.2019.06.005_b0120","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.gastro.2015.09.011","article-title":"Sofosbuvir inhibits hepatitis e virus replication in vitro and results in an additive effect when combined with ribavirin","volume":"150","author":"Dao Thi","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.06.005_b0125","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/hep.30546","article-title":"No clear evidence for an effect of sofosbuvir against hepatitis E virus in organ transplant patients","volume":"69","author":"Kamar","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.06.005_b0130","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1172\/JCI93024","article-title":"Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection","volume":"127","author":"Kah","year":"2017","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jhep.2019.06.005_b0135","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/liv.13521","article-title":"Hepatitis E virus ORF 1 induces proliferative and functional T-cell responses in patients with ongoing and resolved hepatitis E","volume":"38","author":"Al-Ayoubi","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2019.06.005_b0140","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/gutjnl-2015-311109","article-title":"Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver","volume":"66","author":"Sayed","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.06.005_b0145","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jhep.2016.01.011","article-title":"Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation","volume":"64","author":"Allweiss","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.06.005_b0150","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1128\/JVI.00114-16","article-title":"Hepatitis E virus (HEV) genotype 3 infection of human liver chimeric mice as a model for chronic HEV infection","volume":"90","author":"Van de Garde","year":"2016","journal-title":"J Virol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827819303496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827819303496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:35:58Z","timestamp":1759174558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827819303496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0168827819303496"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2019.06.005","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2019.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}